Skip to the page

Data / Drug companies / Nitrofurantoin

Nitrofurantoin: 28 companies and 36 products in the FDA NDC directory

Nitrofurantoin is listed in the FDA National Drug Code Directory by 28 companies, with 36 products in commercial distribution. 35 of the products (97.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule; suspension; for suspension, and the newest product started marketing on July 2, 2025.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
28
Products
36
Generic (ANDA) products
35 (97.2%)
Application numbers
12
Routes
Oral
openFDA record search
api.fda.gov

Companies that list nitrofurantoin

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Alembic Pharmaceuticals Inc.3capsuleGeneric drugs (ANDA)July 1, 2021
Alembic Pharmaceuticals Limited3capsuleGeneric drugs (ANDA)July 1, 2021
Bryant Ranch Prepack3capsuleGeneric drugs (ANDA)January 1, 2018
PD-Rx Pharmaceuticals, Inc.2capsuleGeneric drugs (ANDA)January 1, 2018
Remedyrepack Inc.2capsuleGeneric drugs (ANDA)December 20, 2024
Amneal Pharmaceuticals LLC1suspensionGeneric drugs (ANDA)March 24, 2011
Amneal Pharmaceuticals NY LLC1suspensionGeneric drugs (ANDA)May 31, 2021
Ani Pharmaceuticals, Inc.1suspensionGeneric drugs (ANDA)April 17, 2023
Aurobindo Pharma Limited1suspensionGeneric drugs (ANDA)May 11, 2023
Biocon Pharma Inc.1suspensionGeneric drugs (ANDA)November 15, 2024
Bryant Ranch Prepack1capsuleGeneric drugs (ANDA)January 1, 2018
Bryant Ranch Prepack1capsuleGeneric drugs (ANDA)January 1, 2018
Camber Pharmaceuticals, Inc.1suspensionGeneric drugs (ANDA)July 2, 2025
Direct_Rx1capsuleGeneric drugs (ANDA)January 18, 2022
Lupin Pharmaceuticals,Inc.1suspensionGeneric drugs (ANDA)May 21, 2015
Micro Labs Limited1capsuleGeneric drugs (ANDA)April 1, 2024
NorthStar RxLLC1suspensionGeneric drugs (ANDA)April 17, 2023
Novel Laboratories, Inc.1suspensionGeneric drugs (ANDA)September 8, 2014
NuCare Pharmaceuticals,Inc.1capsuleGeneric drugs (ANDA)January 1, 2018
Preferred Pharmaceuticals Inc.1capsuleGeneric drugs (ANDA)September 16, 2022
Proficient Rx LP1capsuleGeneric drugs (ANDA)January 1, 2018
Proficient Rx LP1capsuleGeneric drugs (ANDA)July 1, 2021
Redpharm Drug1capsuleGeneric drugs (ANDA)January 1, 2018
Rising Pharma Holdings, Inc.1suspensionAuthorized generics (NDA)February 1, 2024
Rising Pharma Holdings, Inc.1suspensionGeneric drugs (ANDA)May 11, 2023
Somerset Therapeutics, LLC1for suspensionGeneric drugs (ANDA)February 26, 2025
St. Mary's Medical Park Pharmacy1capsuleGeneric drugs (ANDA)October 24, 2023
Trigen Laboratories, LLC1capsuleGeneric drugs (ANDA)January 1, 2018

Dosage forms

Dosage formProductsShare
Capsule2466.7%
Suspension1130.6%
For suspension12.8%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)3597.2%
Authorized generics (NDA)12.8%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.